Introducing Medisca Nutraceuticals

Download in electronic PDF format for $25



Search the Complete Journal Archives

Using ACDs in the Practice of Pharmacy

Author(s):  Kastango Eric S

Issue:  Jan/Feb 2005 - Sterile Preparations
View All Articles in Issue

Abstract:  Several sections of the recently published USP<797> chapter of the United States Pharmacopeia (USP) address the use of automatic compounding devices (ACDs) and offer guidelines for ensuring that they operate properly and within acceptable tolerance limits. ACDs are designed to accurately transfer volumes of fluid from one container into another. All pharmacies using ACDs must develop a quality system to ensure the safety and accuracy of formulations prepared by ACD. A quality system should incorporate a hazard analysis, critical control points plan, which involves definition of steps in any ACD compounding process and identification of potential hazards in the process. The pharmacy also must document appropriate maintenance, calibration, and functioning of the ACD equipment as well as training of personnel to carry out these activities. One section of USP<797> focuses on the accuracy and precision of ACDs in preparing parenteral nutrition solutions. Optimal operating characteristics of an ACD for preparation of these solutions are discussed.

Related Keywords: Eric S. Kastango, MBA, RPh, FASHP, automatic compounding devices, quality control, hazard analysis, contamination control points plan, HACCP plan, United States Pharmacopeia, USP Chapter <797>, parenteral nutrition

Related Categories: PARENTERALS, STERILE PREPARATIONS, TECHNOLOGY, QUALITY CONTROL, UNITED STATES PHARMACOPEIA CONVENTIONS, FDA

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Using ACDs in the Practice of Pharmacy Kastango Eric S Jan/Feb 2005 15-21 Buy
Microbial Air-Sampling Equipment, Part 1: Meeting United States Pharmacopeia Chapter <797> Standards Kastango Eric S May/Jun 2008 216-229 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 6: 2008 Revisions to Chapter <797> Allen Loyd V Jr, Okeke Claudia C Mar/Apr 2008 136-144 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 13: Environmental Quality and Control Allen Loyd V Jr, Okeke Claudia C May/Jun 2009 234-238 Buy
Basics of Compounding: United States Pharmacopeia General Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 10: First Revision: The Main Changes, Events, and Rationale Okeke Claudia C, Newton David W, Kastango Eric S, Allen Loyd V Jr Nov/Dec 2008 530-536 Buy
Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 3: Risk Levels Allen Loyd V Jr, Okeke Claudia C Sep/Oct 2007 404-410 Buy
A Primer on USP Chapter 797, "Pharmaceutical Compounding - Sterile Preparations," and USP Process for Drug and Practice Standards Newton David W, Trissel Lawrence A Jul/Aug 2004 251 Buy
Quality-Control Analytical Methods: A Discussion of United States Pharmacopeia Chapter <71> Sterility Tests Kupiec Thomas C Sep/Oct 2007 400-403 Buy
Basics of Compounding: Considerations for Implementing United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations, Part 14: Environmental Quality and Control (Continued) Okeke Claudia C, Allen Loyd V Jr Jul/Aug 2009 322-329 Buy
Update on the Proposed Revision Process for United States Pharmacopeia Chapter <797> Pharmaceutical Compounding--Sterile Preparations Okeke Claudia C Jul/Aug 2007 302-305 Buy